TODAY : Sunday, 14 December 2025
Code
IRRA
Title
PT Itama Ranoraya Tbk
Address
Head Office:
Address:MT. Haryono Square 1th Floor Unit 1
Jl. Otto Iskandardinata Raya No. 390 Jakarta Timur 13330
Phone:(021) 290 67207
Fax:(021) 290 67208
E-mail:corsec@itama.co.id
Website:www.itama.co.id
Branch Office:
Jl. Surapati No.5 Bandung
Jawa Barat, Indonesia 40132
Phone:(022) 253 4360
Fax:(022) 253 4526
E-mail:corsec@itama.co.id
Website:www.itama.co.id
Background

Based on the decisions of the shareholders, the purpose of the Entity is do business in the wholesale trade in laboratory equipment, pharmaceuticals and medicine. Currently the main activity of the Entity is
operating in procurement of health goods while in 2017 the Entity is engaged in the distributor of medicines.
Business cp product

Based on the decisions of the shareholders, the purpose of the Entity is do business in the wholesale trade in laboratory equipment, pharmaceuticals and medicine. Currently the main activity of the Entity is
operating in procurement of health goods while in 2017 the Entity is engaged in the distributor of medicines.
Subsidiary affiliation
Commissioners
President Commissioner: Dr. Tjandra Yoga Aditama
CommissionerDrs.H. Wirdhan Denny
Independent Commissioner: Roy Edison Maningkas
Per 30 Sep 2022
Directors
President Director: Heru Firdausi Syarif
Director: Nanan Meinanta Lasahido
Director: Hendry Herman
Director: Dodi Nurzani
Per 30 Sep 2022
Underwriter
PT. BNI Sekuritas
PT. Mirae Asset Sekuritas Indonesia
Share registrar
PT. Adimitra Jasa Korpora
Share holders
ShareholdersShares%
PT. Global Dinamika Kencana121458380075.91
PT. Numedik Jaya840000005.25
DR. Tjandra Yoga Aditama2036000.01
Public25430780015.9
Treasury Stock469048002.93
As of Jun 30, 2023
History stocks

Type of ListingDatePrice## of SharesTotal Listed Shares

IPO @ Rp 37415-Oct-2019504000000001600000000
Other infos

Created date
2023-09-25 15:38:47
Revised date
2023-09-25 15:38:47
Finance
 
PT Itama Ranoraya Tbk
 
2023, 2022, 2021, 2020, 2019, 2018, 2017, 2016,
Financial Statetment Date
Fiscal Year Ends
Months Covered in Income St
 
Summary Covered in Income St
Cash and Cash Equivalents
Receivables
Inventories
Current Assets
Fixed Assets
Other Assets
Non Current Assets
Total Assets
Current Liabilities
Longterm Liabilities
Total Liabilities
Authorized
Paid-up Capital
Par Value
Paid-up Capital Shares
Retained Earnings
Total Equity
Minority Interest
 
Summary of Income Statement
Total Sales
Cost of Good Sold
Gross Profit
Operating Profit
Other Income
Earning Before Tax
Tax
Net Income
Close Price
 
Per Share Data (Rp)
Eps (annualized)
Book Value
 
Financial Ratios
Debt Equity Ratio (X)
Roa(%)
Roe(%)
Npm(%)
Opm(%)
Gross Profit Margin (%)
Total Assets Turnover
 
Cash Flow
CF from Operation Activities
CF from Investing Activities
CF from Financing Activities
Net Increase in Cash & Cash Equivalent
Cash & Cash Equivalent at Beginning of the Year
Cash & Cash Equivalent at The End of the Year
2019-12-31 2019-03-31
Dec Dec
12 3
 
 
42,860,683.91 380,218.99
145,067,995.46 51,342,945.71
11,159,437.08 11,349,910.69
309,969,923.75 85,514,917.07
12,393,333.38 11,479,288.19
0.00 0.00
15,463,054.63 11,778,268.69
325,432,978.38 97,293,185.76
89,217,392.14 27,507,691.45
1,046,485.00 1,195,922.00
90,263,877.14 28,703,613.45
105.00 105.00
80,000,000.00 20,500,000.00
50.00 100,000.00
1,600,000.00 205.00
34,560,705.02 48,611,106.57
235,169,101.24 68,589,572.32
0.00 0.00
 
 
281,751,897.00 26,388,527.76
222,158,029.39 20,890,456.09
59,593,867.61 5,498,071.67
44,090,157.48 2,891,293.17
0.00 97,964.11
44,090,157.48 2,989,257.28
10,884,949.25 733,647.50
33,205,208.23 2,255,609.78
650.00 0.00
 
 
20.75 44,011.90
146.98 334,583.28
 
 
0.38 0.42
10.20 9.27
14.12 13.15
11.79 8.55
15.65 10.96
21.15 20.84
0.87 0.27
 
 
-8,180,573.58 -18,006,872.29
-4,566,586.55 -1,036,018.04
35,434,734.72 -750,000.00
22,687,574.59 -19,792,890.33
20,173,109.33 20,173,109.33
42,860,683.91 380,218.99